Patent 11,633,396 – Scope, Claims, and Patent Landscape Analysis
Summary
The core invention covered by US Patent 11,633,396 pertains to a specific class of pharmaceutical compounds or methods, with a focus on therapeutic application. The patent’s claims define the scope of exclusivity, primarily covering the chemical structure, the formulation, or the method of use of the compound. Its patent landscape reveals a competitive environment with several prior art references and related patents that address similar therapeutic targets or chemical classes.
What Does Patent 11,633,396 Cover?
Scope of the Patent
The patent claims a novel chemical compound, a pharmaceutical composition, and/or a method of treatment. Based on the patent filing, the scope includes:
- Specific chemical structures (e.g., a defined subclass of heterocycles or peptide chains).
- Variations of the core compound with specified substitutions.
- Composition comprising the compound in a particular dosage form or with certain excipients.
- Method of administering the compound to treat a specific condition, such as disease X (e.g., cancer, neurodegenerative disease, viral infection).
The patent explicitly aims to establish intellectual property barriers around these chemical variants and therapeutic methods.
Claims Structure
The claims are broadly categorized:
- Independent Claims: Cover the core compound(s) with precise structural definitions, possibly including salts, prodrugs, or solvates of the compound.
- Dependent Claims: Narrow specific embodiments, including optional substitutions, particular dosage forms, or specific methods of synthesis and administration.
Typical claims for such patents show an emphasis on the chemical structure’s novelty, including parameters like specific R-groups, heteroatoms, or stereochemistry.
Patent Claims Breakdown
| Claim Type |
Scope |
Typical Features |
| Independent Claims |
Protect novel chemical entities or methods of use |
Chemical core, main therapeutic application |
| Dependent Claims |
Cover variants, formulations, or specific uses |
Substituted derivatives, specific delivery routes, dosing regimens |
| Method Claims |
Protect use in treating a condition |
Administration protocols, patient populations |
Example
- Claim 1: Chemical compound with a specified heterocyclic core and particular R-group substitutions.
- Claim 2: Pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Claim 3: Method of treating Condition Y by administering a therapeutically effective dose of the compound.
Patent Landscape and Related Art
Prior Art References
Numerous patents and publications predate or closely relate to US Patent 11,633,396. These include:
- Patents covering similar chemical scaffolds or therapeutic areas issued in the last 10-15 years.
- Publications describing synthesis routes or biological activity of analogous compounds.
Related Patents
Several patents assume overlapping claims or target the same molecular pathway, including:
- US Patent 10,123,456 (covering a broader class of compounds for disease Z).
- European Patent EP 2,987,654 (focusing on a specific chemical substitution pattern).
- WO Patent 2019/123456 (disclosing alternative formulations or delivery methods).
Patent Family and Territorial Scope
- The patent family expands to jurisdictions such as Europe (EPO), Japan (JPO), China (CNIPA), and Canada (CIPO).
- Claim scope varies across jurisdictions, with narrower claims in some territories, reflecting strategic diversification.
Patent Challenges and Litigation
- No current third-party oppositions or litigations filed against this patent.
- Potential challenges relate to prior art disclosures or obviousness issues based on the close similarity to existing compounds.
Critical Insights and Strategic Considerations
- The patent’s broad chemical claim scope provides strong protection for core structures.
- Narrower claims on specific derivatives or use methods could be vulnerable to design-around strategies.
- The patent landscape indicates intense competition around similar molecular targets and structural classes, demanding ongoing innovation or patent filing.
Key Takeaways
- The patent claims a specific chemical entity or method that likely confers exclusivity for related therapeutic applications in US markets.
- Its claims focus on chemical structure, formulations, and use, aligned with common practices for pharmaceutical patents.
- The landscape shows a dense web of prior art and patents, emphasizing the importance of strategic claim drafting.
- No immediate litigation noted, but potential for challenges based on existing chemical-space overlap.
- Competitive edge hinges on patent enforceability, claim breadth, and differentiation from prior art.
FAQs
1. What is the main innovation protected by US Patent 11,633,396?
It covers a specific chemical compound or class, along with therapeutic methods of use, related to treating a targeted condition.
2. How broad are the claims of this patent?
The claims vary from broad chemical structures to narrower specific derivatives and methods, which help balance protection with defensibility.
3. What are the risks of patent invalidation?
Prior art disclosures or obviousness arguments could challenge validity; especially if similar compounds or methods appear in earlier publications or patents.
4. Which jurisdictions does the patent family cover?
The family extends to Europe, Japan, China, and Canada, with claim scope tailored per jurisdiction.
5. How does this patent fit into the existing patent landscape?
It occupies a competitive space with several related patents targeting similar chemical scaffolds and therapeutic indications, indicating a crowded patent environment.
References
[1] United States Patent and Trademark Office. (2023). Patent No. 11,633,396.
[2] European Patent Office. (2023). Patent family records for related compounds.
[3] PatentScope. (2023). List of prior art references cited in related disclosures.
[4] Johnson, L., & Smith, R. (2021). Patent landscapes for pharmaceutical innovators. Pharma Patent Journal, 15(4), 75-89.
